Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria

Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria

Episodes of delayed hemolysis 2–6 weeks after treatment of severe malaria with intravenous artesunate have been described. We performed a prospective observational study of patients with uncomplicated malaria to investigate whether posttreatment hemolysis also occurs after oral artemisinin-based com...

Full description

Bibliographic Details
Main Authors:	Florian Kurth, Tilman Lingscheid, Florian Steiner, Miriam S. Stegemann, Sabine Bélard, Nikolai Menner, Peter Pongratz, Johanna Kim, Horst von Bernuth, Beate Mayer, Georg Damm, Daniel Seehofer, Abdulgabar Salama, Norbert Suttorp, Thomas Zoller
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2016-08-01
Series:	Emerging Infectious Diseases
Subjects:	malaria uncomplicated malaria Plasmodium falciparum parasites hemolysis artemisinin
Online Access:	https://wwwnc.cdc.gov/eid/article/22/8/15-1905_article

Similar Items

Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
by: Brioni R. Moore, et al.
Published: (2017-10-01)

Severe Delayed Hemolysis Associated with Regulated Parenteral Antimalarial Drug
by: Julia Lee, et al.
Published: (2015-01-01)

Post-artemisinin delayed hemolysis after oral therapy for P. falciparum infection
by: Christian C. Conlon, et al.
Published: (2020-01-01)

Artesunate-induced hemolysis in severe complicated malaria – A diagnostic challenge: A case report and literature review of anemia in malaria
by: Sundus Sardar, et al.
Published: (2021-01-01)

Safety, pharmacokinetics and efficacy of artemisinins in pregnancy
by: Veronica Ades
Published: (2011-05-01)

Severe and uncomplicated falciparum malaria in children from three regions and three ethnic groups in Cameroon: prospective study
by: Achidi Eric A, et al.
Published: (2012-06-01)

Use of chloroquine in uncomplicated falciparum malaria chemotherapy : The past, the present and the future
by: Balogun S T, et al.
Published: (2010-01-01)

Effect of ABO blood group on asymptomatic, uncomplicated and placental Plasmodium falciparum infection: systematic review and meta-analysis
by: Abraham Degarege, et al.
Published: (2019-01-01)

Haptoglobin gene diversity and incidence of uncomplicated malaria among children in Iganga, Uganda
by: Catherine N. Lwanira, et al.
Published: (2020-11-01)

In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
by: Moussa Lingani, et al.
Published: (2020-01-01)

Artemisinin and Its Synthetic Derivatives as a Possible Therapy for Cancer
by: Enrique Konstat-Korzenny, et al.
Published: (2018-02-01)

Prevalence of uncomplicated malaria in a paediatrics outpatient department of a tertiary health institution in Sokoto, Nigeria
by: N M Jiya, et al.
Published: (2010-01-01)

Artemisinin resistance: Cause for worry?
by: Anurag Khera, et al.
Published: (2019-01-01)

Artesunate-amodiaquine versus artesunatesulfadoxine- pyrimethamine for uncomplicated falciparum malaria in children
by: Novie H. Rampengan, et al.
Published: (2014-02-01)

Examining the role of K13 in artemisinin-resistant Plasmodium falciparum malaria
by: Stokes, Barbara
Published: (2020)

Efficacy of artemether .. lumefantrine and artesunate-amodiaquine for treating uncomplicated falciparum malaria in children
by: Tri Faranita, et al.
Published: (2012-10-01)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
by: Hadjar Siswantoro, et al.
Published: (2015-01-01)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
by: Hadjar Siswantoro, et al.
Published: (2015-01-01)

Systematic literature review and meta-analysis of the efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: methodological challenges
by: Makoto Saito, et al.
Published: (2017-12-01)

Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated <it>falciparum</it> malaria in calabar, Nigeria
by: Meremikwu Martin M, et al.
Published: (2012-12-01)

Comparison of the efficacy of artesunate-amodiaquine with quinine ... clindamycin for treatment of uncomplicated falciparum malaria in children
by: Purnama Fitri, et al.
Published: (2009-04-01)

“I feel so bad but have nothing to do.” Exploring Ugandan caregivers’ experiences of parenting a child with severe malaria and subsequent repeated uncomplicated malaria
by: Ann J. Nakitende, et al.
Published: (2018-10-01)

Malaria profiles and challenges in artemisinin resistance containment in Myanmar
by: Thet Wai Nwe, et al.
Published: (2017-04-01)

Efficacy and safety of Camosunate for the treatment of uncomplicated malaria in the University of Benin Teaching Hospital, Benin City, Nigeria
by: Damien Uyagu, et al.
Published: (2013-10-01)

Prevalence of K13 mutation and Day-3 positive parasitaemia in artemisinin-resistant malaria endemic area of Cambodia: a cross-sectional study
by: Soy Ty Kheang, et al.
Published: (2017-09-01)

Discovery of artemisinin: The Chinese wonder drug
by: Padmaja Udaykumar
Published: (2014-01-01)

Efficacy and safety of artemisinin-naphthoquine <it>versus</it> dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia
by: Tjitra Emiliana, et al.
Published: (2012-06-01)

A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago
by: Daniel Kabonge Kaye,1 Ruth Nshemerirwe,1 Twaha Serunjogi Mutyaba,1 Grace Ndeezi.2
Published: (2008-04-01)

The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated <it>Plasmodium falciparum</it> malaria in south-central Vietnam
by: Thanh Nguyen, et al.
Published: (2012-06-01)

Artemisinin-resistant malaria and a prevention strategy
by: Francis M Malwal
Published: (2020-12-01)

Treatment of adults with acute uncomplicated malaria with azithromycin and chloroquine in India, Colombia, and Suriname
by: Kshirsagar NA, et al.
Published: (2017-10-01)

Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Chewaka District, Ethiopia
by: Abdulhakim Abamecha, et al.
Published: (2020-07-01)

Comparative efficacy of artesunate and sulphadoxine-pyrimethamine combination with artesunate and amodiaquine combination in uncomplicated falciparum malaria in children
by: Jose Meky Mandei, et al.
Published: (2008-08-01)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
by: Prakash Ghimire, et al.
Published: (2018-08-01)

Safety of Artemisinin Derivatives in the First Trimester of Pregnancy: A Controversial Story
by: Sarah D’Alessandro, et al.
Published: (2020-07-01)

Current Antimalarial Therapies and Advances in the Development of Semi-Synthetic Artemisinin Derivatives
by: LUIZ C.S. PINHEIRO, et al.

Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
by: Mwaka A. Kakolwa, et al.
Published: (2018-10-01)

The efficacy and safety of artemisinin-based combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in non-pregnant adults and children : a systematic review.
by: Zani, Babalwa.
Published: (2013)

Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam
by: Nguyen Van Hong, et al.
Published: (2014-07-01)

Effect of artemisinin-piperaquine treatment on the electrocardiogram of malaria patients
by: Wanting Wu, et al.
Published: (2019-05-01)